Publicacións (82) Publicacións de Jacobo José Pardo Seco

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  4. GUANIN: an all-in-one GUi-driven analyzer for NanoString interactive normalization

    Bioinformatics, Vol. 40, Núm. 8

  5. Host gene expression signatures to identify infection type and organ dysfunction in children evaluated for sepsis: a multicentre cohort study

    The Lancet Child and Adolescent Health, Vol. 8, Núm. 5, pp. 325-338

  6. Interferon gene expression declines over time post-COVID infection and in long COVID patients

    Infectious Diseases

  7. Multi-tissue transcriptomics of a unique monozygotic discordant twin case of severe progressive osseous heteroplasia

    Genes and Diseases, Vol. 11, Núm. 3

  8. Mycoplasma pneumoniae at the rise not only in China: rapid increase of Mycoplasma pneumoniae cases also in Spain

    Emerging Microbes and Infections

  9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  10. Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis Syndrome

    Clinical and Experimental Allergy

  11. Whole exome sequencing identifies new susceptibility candidates underlying community-acquired pneumonia

    Genes and Diseases, Vol. 11, Núm. 6

2023

  1. Adeno-associated virus 2 infection in children with non-A–E hepatitis

    Nature, Vol. 617, Núm. 7961, pp. 555-563

  2. Biobanking and consenting to research: a qualitative thematic analysis of young people’s perspectives in the North East of England

    BMC Medical Ethics, Vol. 24, Núm. 1

  3. COVID-19 vaccine effectiveness in children by age groups. A population-based study in Galicia, Spain

    Pediatric Allergy and Immunology, Vol. 34, Núm. 10

  4. Emergency medical services utilisation among febrile children attending emergency departments across Europe: an observational multicentre study

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 3939-3947

  5. Genomic investigations of unexplained acute hepatitis in children

    Nature, Vol. 617, Núm. 7961, pp. 564-573

  6. Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens

    iScience, Vol. 26, Núm. 8

  7. Improving Influenza Vaccine Acceptance in Children Leveraging on COVID-19 Vaccination Lessons

    Archivos de Bronconeumologia, Vol. 59, Núm. 8, pp. 531-533

  8. Music compensates for altered gene expression in age-related cognitive disorders

    Scientific Reports, Vol. 13, Núm. 1

  9. Relationship between molecular pathogen detection and clinical disease in febrile children across Europe: a multicentre, prospective observational study

    The Lancet Regional Health - Europe, Vol. 32